Inactivation of von Hippel-Lindau increases ovarian cancer cell aggressiveness through the HIF1α/miR-210/VMP1 signaling pathway

International Journal of Molecular Medicine

Volumn 33, Issue 5, 2014, Pages 1236-1242

  Liu, Ting ^a   Zhao, L E ^a   Chen, Wei ^a   Li, Zhen ^a   Hou, Huilian ^a   Ding, Lu ^a   Li, Xu ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

MicroRNA 210; Ovarian cancer; Von Hippel Lindau

Indexed keywords

GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIFICIGUAT; MEMBRANE PROTEIN; MICRORNA 210; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VACUOLE MEMBRANE PROTEIN 1; VON HIPPEL LINDAU PROTEIN; 3-(5'-HYDROXYMETHYL-2'-FURYL)-1-BENZYLINDAZOLE; INDAZOLE DERIVATIVE; MICRORNA; MIRN210 MICRORNA, HUMAN;

ARTICLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENE INACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; OVARIAN CANCER CELL LINE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARY TUMOR;

FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INDAZOLES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICRORNAS; OVARIAN NEOPLASMS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84899570199     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1661     Document Type: Article

References (40)

1. de Paulsen N, Brychzy A, Fournier MC, et al: Role of transforming growth factor-alpha in von Hippel-Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis. Proc Natl Acad Sci USA 98: 1387-1392, 2001. (Pubitemid 32165508)
2. Vanharanta S, Shu W, Brenet F, et al: Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer. Nat Med 19: 50-56, 2013.
3. Kapitsinou PP and Haase VH: The VHL tumor suppressor and HIF: insights from genetic studies in mice. Cell Death Differ 15: 650-659, 2008. (Pubitemid 351405068)
4. Gong K, Zhang N, Zhang K and Na Y: The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma. Int J Mol Med 26: 907-912, 2010.
5. Minet E, Michel G, Remacle J and Michiels C: Role of HIF-1 as a transcription factor involved in embryonic development, cancer progression and apoptosis (Review). Int J Mol Med 5: 253-259, 2000.
6. Shen G, Li X, Jia YF, Piazza GA and Xi Y: Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin 34: 336-341, 2013.
7. Chan YC, Banerjee J, Choi SY and Sen CK: miR-210: the master hypoxamir. Microcirculation 19: 215-223, 2012.
8. Chan SY and Loscalzo J: MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 9: 1072-1083, 2010.
9. Neal CS, Michael MZ, Rawlings LH, Van der Hoek MB and Gleadle JM: The VHL-dependent regulation of microRNAs in renal cancer. BMC Med 8: 64, 2010.
10. Yang W, Sun T, Cao J, Liu F, Tian Y and Zhu W: Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro. Exp Cell Res 318: 944-954, 2012.
11. Fasanaro P, Greco S, Lorenzi M, et al: An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem 284: 35134-35143, 2009.
12. Tsuchiya S, Fujiwara T, Sato F, et al: MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem 286: 420-428, 2011.
13. Ying Q, Liang L, Guo W, et al: Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology 54: 2064-2075, 2011.
14. Ropolo A, Grasso D, Pardo R, et al: The pancreatitis-induced vacuole membrane protein 1 triggers autophagy in mammalian cells. J Biol Chem 282: 37124-37133, 2007.
15. Sauermann M, Sahin O, Sültmann H, et al: Reduced expression of vacuole membrane protein 1 affects the invasion capacity of tumor cells. Oncogene 27: 1320-1326, 2008. (Pubitemid 351294693)
16. Ozdemir F, Altinisik J, Karateke A, Coksuer H and Buyru N: Methylation of tumor suppressor genes in ovarian cancer. Exp Ther Med 4: 1092-1096, 2012.
17. Osada R, Horiuchi A, Kikuchi N, et al: Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma. Hum Pathol 38: 1310-1320, 2007. (Pubitemid 47247486)
18. Semenza GL: HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8 (Suppl 4): S62-S67, 2002.
19. Rothe F, Ignatiadis M, Chaboteaux C, et al: Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer. PLoS One 6: e20980, 2011.
20. Redova M, Poprach A, Besse A, et al: MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma. Tumour Biol 34: 481-491, 2013.
21. Giannakakis A, Sandaltzopoulos R, Greshock J, et al: miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther 7: 255-264, 2008. (Pubitemid 351590433)
22. Guo L, Yang LY, Fan C, Chen GD and Wu F: Novel roles of Vmp1: inhibition metastasis and proliferation of hepatocellular carcinoma. Cancer Sci 103: 2110-2119, 2012.
23. Liu F, Niu Y, Liu N, et al: Expression of vacuole membrane protein 1 and its prognostic value in invasive ductal carcinoma of the breast. Zhonghua Bing Li Xue Za Zhi 42: 86-89, 2013 (In Chinese).
24. Moch H: Von-Hippel-Lindau (VHL) protein function by initiation and progression of renal cancer. Pathologe 29 (Suppl 2): 149-152, 2008 (In German).
25. Ivanov SV, Ivanova AV, Salnikow K, Timofeeva O, Subramaniam M and Lerman MI: Two novel VHL targets, TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors. Biochem Biophys Res Commun 370: 536-540, 2008.
26. Yu F, White SB, Zhao Q and Lee FS: HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci USA 98: 9630-9635, 2001. (Pubitemid 32769354)
27. Kaelin WG Jr: The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing. Biochem Biophys Res Commun 338: 627-638, 2005.
28. Semenza GL: Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732, 2003.
29. Zia MK, Rmali KA, Watkins G, Mansel RE and Jiang WG: The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells. Int J Mol Med 20: 605-611, 2007.
30. Choueiri TK, Fay AP, Gagnon R, et al: The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma. Clin Cancer Res 19: 5218-5226, 2013.
31. Mace TA, Collins AL, Wojcik SE, Croce CM, Lesinski GB and Bloomston M: Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells. J Surg Res 2: 855-860, 2013.
32. Crosby ME, Kulshreshtha R, Ivan M and Glazer PM: MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res 69: 1221-1229, 2009.
33. Camps C, Buffa FM, Colella S, et al: hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14: 1340-1348, 2008. (Pubitemid 351413913)
34. Feng Y, Zhang S and Huang X: A robust TALENs system for highly efficient mammalian genome editing. Sci Rep 4: 3632, 2014.
35. Liu Y, Han Y, Zhang H, et al: Synthetic miRNA-mowers targeting miR-183-96-182 cluster or miR-210 inhibit growth and migration and induce apoptosis in bladder cancer cells. PLoS One 7: e52280, 2012.
36. Cui H, Grosso S, Schelter F, Mari B and Kruger A: On the prometastatic stress response to cancer therapies: evidence for a positive co-operation between TIMP-1, HIF-1á, and miR-210. Front Pharmacol 3: 134, 2012.
37. Huang X, Ding L, Bennewith KL, et al: Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell 35: 856-867, 2009.
38. Evans AJ, Russell RC, Roche O, et al: VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Mol Cell Biol 27: 157-169, 2007. (Pubitemid 46013241)
39. Esteban MA, Tran MG, Harten SK, et al: Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer Res 66: 3567-3575, 2006.
40. Zhou Q, Chen T, Ibe JC, Raj JU and Zhou G: Knockdown of von Hippel-Lindau protein decreases lung cancer cell proliferation and colonization. FEBS Lett 586: 1510-1515, 2012.